Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | The Biotech Growth Trust PLC (Ordinary Share) | +52.51% |
| NAV | The Biotech Growth Trust PLC (Ordinary Share) | +47.99% |
| Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | +33.47% |
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
More ▼
Key statistics
On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,255.00, -3.46% below its 52-week high of 1,300.00, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 20.58m |
|---|---|
| Market cap | 255.18m GBP |
| Total assets | 316.03m GBP |
| Total expense ratio | -- |
| High | 1,260.00 |
| Low | 1,230.00 |
| Previous close | 1,240.00 |
| Average volume | 76.26k |
|---|---|
| YTD Change | +4.58% |
| Beta | 0.6322 |
| Diluted NAV (est) | 1,353.61 |
| Diluted NAV (last pub) | 1,359.83 |
| Premium/Discount | -7.81% |
| Net Gearing | +11.69% |
Data delayed at least 20 minutes, as of Feb 27 2026 16:47 GMT.
More ▼


